 Analysis: Statistical analysis will be conducted using Stata software, version 13 StataCorp, College Station, Texas, USA. Baseline characteristics for treatment and wait-list groups will be compared using a Students t-test for continuous data and Chi squared or Fishers exact test for categorical variables. Analysis for the primary objective and secondary objective 1 will be performed using linear mixed-effects modelling with data from three repeated measures baseline, 7 weeks, 18 weeks. A p value of less than 0.05 will be considered indicative of statistical significance. The primary analysis will use intention to treat principles, but a secondary analysis to investigate efficacy for those that complete 75 of visits will be performed as well per protocol analysis. Predictors of response change in SMFA-DI will be determined using a series of multiple regression models. 